SeaCrest Wealth Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-730
| Closed | -$181K | – | 1627 |
|
|
2022
Q2 | $181K | Buy |
730
+40
| +6% | +$9.92K | 0.02% | 644 |
|
|
2022
Q1 | $229K | Buy |
690
+40
| +6% | +$13.3K | 0.03% | 611 |
|
|
2021
Q4 | $233K | Hold |
650
| – | – | 0.03% | 598 |
|
|
2021
Q3 | $212K | Hold |
650
| – | – | 0.03% | 612 |
|
|
2021
Q2 | $203K | Sell |
650
-13
| -2% | -$4.06K | 0.02% | 645 |
|
|
2021
Q1 | $211K | Sell |
663
-7
| -1% | -$2.23K | 0.03% | 596 |
|
|
2020
Q4 | $217K | Buy |
+670
| New | +$217K | 0.03% | 543 |
|
|
2019
Q2 | – | Sell |
-555
| Closed | -$159K | – | 2012 |
|
|
2019
Q1 | $159K | Hold |
555
| – | – | 0.03% | 539 |
|
|
2018
Q4 | $180K | Sell |
555
-123
| -18% | -$39.9K | 0.04% | 452 |
|
|
2018
Q3 | $305K | Sell |
678
-247
| -27% | -$111K | 0.05% | 385 |
|
|
2018
Q2 | $378K | Sell |
925
-50
| -5% | -$20.4K | 0.07% | 315 |
|
|
2018
Q1 | $284K | Hold |
975
| – | – | 0.05% | 380 |
|
|
2017
Q4 | $183K | Buy |
+975
| New | +$183K | 0.03% | 525 |
|